Back to news

Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference

Globe Newswire•18/11/2026•07:00 ET
0

Key Highlights

  • ➤Aquestive management to present at Piper Sandler healthcare conference December 2
  • ➤CEO Daniel Barber will host investor one-on-ones in New York City
  • ➤Anaphylm and AQST-108 remain in development for targeted indications
  • ➤Aquestive manufactures four commercialized products marketed by licensees across six continents

Expert Statements

Daniel Barber, President and CEO of Aquestive Therapeutics

“The Company will also be hosting one-on-ones with investors that day.”

WARREN, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a biopharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science, announced today that the management team will participate in the Piper Sandler 38(th) Annual Healthcare Conference December 1-3, 2026, in New York City.

Aquestive President and CEO Daniel Barber will be presenting on Wednesday, December 2, 2026, at 10:30 am ET. The Company will also be hosting one-on-ones with investors that day.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in